Evolving understanding of antibody-dependent enhancement (ADE) of SARS-CoV-2

Since immune system and internal environment in vivo are large and complex, the interpretation of the observed immune effect from the perspective of a single immune cell or antibody seems a little feeble. Many studies have shown that specific antibodies against “ former” viruses have a reduced abili...

Full description

Bibliographic Details
Main Authors: Yalong Yang, Fenghua Xu
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-10-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2022.1008285/full
_version_ 1811251568095264768
author Yalong Yang
Yalong Yang
Fenghua Xu
author_facet Yalong Yang
Yalong Yang
Fenghua Xu
author_sort Yalong Yang
collection DOAJ
description Since immune system and internal environment in vivo are large and complex, the interpretation of the observed immune effect from the perspective of a single immune cell or antibody seems a little feeble. Many studies have shown that specific antibodies against “ former” viruses have a reduced ability to neutralize “new” mutant strains. However, there is no comprehensive and clear view of whether there will be Antibody-dependent enhancement (ADE). We review the latest relevant studies, hoping to explain the ADE of SARS-CoV-2 infection sometimes observed in some patients.
first_indexed 2024-04-12T16:22:24Z
format Article
id doaj.art-e768c20eca2b4d0fa8c14d43cdbdc4ed
institution Directory Open Access Journal
issn 1664-3224
language English
last_indexed 2024-04-12T16:22:24Z
publishDate 2022-10-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Immunology
spelling doaj.art-e768c20eca2b4d0fa8c14d43cdbdc4ed2022-12-22T03:25:31ZengFrontiers Media S.A.Frontiers in Immunology1664-32242022-10-011310.3389/fimmu.2022.10082851008285Evolving understanding of antibody-dependent enhancement (ADE) of SARS-CoV-2Yalong Yang0Yalong Yang1Fenghua Xu2Pharmaceutical Sciences Research Division, Department of Pharmacy, Medical Supplies Center, People’s Liberation Army (PLA) General Hospital, Beijing, ChinaMedical School of Chinese People’s Liberation Army (PLA), Beijing, ChinaPharmaceutical Sciences Research Division, Department of Pharmacy, Medical Supplies Center, People’s Liberation Army (PLA) General Hospital, Beijing, ChinaSince immune system and internal environment in vivo are large and complex, the interpretation of the observed immune effect from the perspective of a single immune cell or antibody seems a little feeble. Many studies have shown that specific antibodies against “ former” viruses have a reduced ability to neutralize “new” mutant strains. However, there is no comprehensive and clear view of whether there will be Antibody-dependent enhancement (ADE). We review the latest relevant studies, hoping to explain the ADE of SARS-CoV-2 infection sometimes observed in some patients.https://www.frontiersin.org/articles/10.3389/fimmu.2022.1008285/fullSARS-CoV-2antibody-dependent enhancement (ADE)mechanismreceptor-mediatedmultiple roles of macrophagescountermeasures
spellingShingle Yalong Yang
Yalong Yang
Fenghua Xu
Evolving understanding of antibody-dependent enhancement (ADE) of SARS-CoV-2
Frontiers in Immunology
SARS-CoV-2
antibody-dependent enhancement (ADE)
mechanism
receptor-mediated
multiple roles of macrophages
countermeasures
title Evolving understanding of antibody-dependent enhancement (ADE) of SARS-CoV-2
title_full Evolving understanding of antibody-dependent enhancement (ADE) of SARS-CoV-2
title_fullStr Evolving understanding of antibody-dependent enhancement (ADE) of SARS-CoV-2
title_full_unstemmed Evolving understanding of antibody-dependent enhancement (ADE) of SARS-CoV-2
title_short Evolving understanding of antibody-dependent enhancement (ADE) of SARS-CoV-2
title_sort evolving understanding of antibody dependent enhancement ade of sars cov 2
topic SARS-CoV-2
antibody-dependent enhancement (ADE)
mechanism
receptor-mediated
multiple roles of macrophages
countermeasures
url https://www.frontiersin.org/articles/10.3389/fimmu.2022.1008285/full
work_keys_str_mv AT yalongyang evolvingunderstandingofantibodydependentenhancementadeofsarscov2
AT yalongyang evolvingunderstandingofantibodydependentenhancementadeofsarscov2
AT fenghuaxu evolvingunderstandingofantibodydependentenhancementadeofsarscov2